Stay updated on Tepotinib & Gefitinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Tepotinib & Gefitinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tepotinib & Gefitinib in NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page content appears unchanged with no additions or deletions impacting core information, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-10-28T17:54:59.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links; replaces v3.1.0.
    Difference
    1%
    Check dated 2025-10-06T08:18:36.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0, indicating a newer release.
    Difference
    0.0%
    Check dated 2025-09-29T04:50:41.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Updated from v3.0.1 to v3.0.2; core content remains unchanged, and the 'Back to Top' link was removed as a minor UI adjustment.
    Difference
    0.1%
    Check dated 2025-09-14T23:08:32.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-07T19:49:01.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, as well as additional drug information for various compounds, while removing some previous location and drug information.
    Difference
    5%
    Check dated 2025-08-31T12:34:12.000Z thumbnail image

Stay in the know with updates to Tepotinib & Gefitinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tepotinib & Gefitinib in NSCLC Clinical Trial page.